Novo Nordisk reported weaker-than-expected net profit for the second quarter, with net profit at just under $3 billion, slightly below forecasts. Earnings before interest and tax also missed expectations. The Danish healthcare company revised its operating profit growth forecast for the rest of the year but raised its sales growth expectations. Shares fell nearly 7%, then recovered slightly. The company's CEO said he expects "attractive growth" in the coming months despite increasing competition and regulatory changes.
Category
🗞
NewsTranscript
00:00It's Benzinga, and here's what's on the block.
00:02Novo Nordisk reported weaker-than-expected net profit for the second quarter, with net
00:06profit at just under $3 billion, slightly below forecasts.
00:11Earnings before interest and tax also missed expectations.
00:14The Danish healthcare company revised its operating profit growth forecast for the rest
00:18of the year, but raised its sales growth expectations.
00:22Shares fell nearly 7 percent, then recovered slightly.
00:25The company's CEO said he expects attractive growth in the coming months, despite increasing
00:29competition and regulatory changes.
00:31For all things money, visit Benzinga.com.